BiotechTube
Home/Pipeline/Early Detection Test for Rheumatoid Arthritis

Early Detection Test for Rheumatoid Arthritis

Rheumatoid Arthritis

DevelopmentActive

Key Facts

Indication
Rheumatoid Arthritis
Phase
Development
Status
Active
Company
Age Labs

About Age Labs

Age Labs is a Norwegian life science company that develops diagnostic tests for early detection of age-related diseases using advanced machine learning on epigenetic datasets. Their pipeline includes a groundbreaking early detection test for rheumatoid arthritis, a biological age predictor, and COVID-19 severity prediction tests, alongside custom biomarker development services for pharmaceutical and nutraceutical industries.

View full company profile

Therapeutic Areas

RheumatologyAgingInfectious Diseases

Other Rheumatoid Arthritis Drugs

DrugCompanyPhase
Piclidenoson (CF101)Can Fite BiopharmaPhase II/III
ERNA-201Eterna TherapeuticsPreclinical
Tc99m TilmanoceptNavidea BiopharmaceuticalsPhase 2/3
Monoclonal Antibody Biosimilar (Anti‑TNF)USV Biologics DivisionPhase 1
Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure)LFBPre-clinical
EYD-001 (Takinib analog)EydisBioPreclinical
LFD-200Lifordi ImmunotherapeuticsPhase 1
MEV-N01MesenbioPre-clinical
CIT-013CitryllPhase 2a
Restem-LRestemPhase 2
ASIT PlatformAhead TherapeuticsPre-clinical
AX-158Artax BiopharmaPhase 2